Toprol XL: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 23: | Line 23: | ||
|} | |} | ||
==[[Toprol XL indications and usage|Indications and Usage]]== | ===[[Toprol XL indications and usage|Indications and Usage]]=== | ||
==[[Toprol XL dosage and administration|Dosage and Administration]]== | ===[[Toprol XL dosage and administration|Dosage and Administration]]=== | ||
==[[Toprol XL dosage forms and strengths|Dosage Forms and Strengths]]== | ===[[Toprol XL dosage forms and strengths|Dosage Forms and Strengths]]=== | ||
==[[Toprol XL contraindications|Contraindications]]== | ===[[Toprol XL contraindications|Contraindications]]=== | ||
==[[Toprol XL warnings and precautions|Warnings and Precautions]]== | ===[[Toprol XL warnings and precautions|Warnings and Precautions]]=== | ||
==[[Toprol XL adverse reactions|Adverse Reactions]]== | ===[[Toprol XL adverse reactions|Adverse Reactions]]=== | ||
==[[Toprol XL drug interactions|Drug Interactions]]== | ===[[Toprol XL drug interactions|Drug Interactions]]=== | ||
==[[Toprol XL use in specific populations|Use in Specific Populations]]== | ===[[Toprol XL use in specific populations|Use in Specific Populations]]=== | ||
==[[Toprol XL overdosage|Overdosage]]== | ===[[Toprol XL overdosage|Overdosage]]=== | ||
==[[Toprol XL description|Description]]== | ===[[Toprol XL description|Description]]=== | ||
==[[Toprol XL clinical pharmacology|Clinical Pharmacology]]== | ===[[Toprol XL clinical pharmacology|Clinical Pharmacology]]=== | ||
==[[Toprol XL nonclinical toxicology|Nonclinical Toxicology]]== | ===[[Toprol XL nonclinical toxicology|Nonclinical Toxicology]]=== | ||
==[[Toprol XL clinical studies|Clinical Studies]]== | ===[[Toprol XL clinical studies|Clinical Studies]]=== | ||
==[[Toprol XL how supplied storage and handling|How Supplied/Storage and Handling]]== | ===[[Toprol XL how supplied storage and handling|How Supplied/Storage and Handling]]=== | ||
==[[Toprol XL patient counseling information|Patient Counseling Information]]== | ===[[Toprol XL patient counseling information|Patient Counseling Information]]=== | ||
==[[Toprol XL labels and packages|Labels and Packages]]== | ===[[Toprol XL labels and packages|Labels and Packages]]=== | ||
Revision as of 02:37, 13 March 2014
 | |
| Clinical data | |
|---|---|
| Trade names | Lopressor, Toprol-xl |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682864 |
| [[Regulation of therapeutic goods |Template:Engvar data]] |
|
| Pregnancy category | |
| Routes of administration | Oral, IV |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 12% |
| Metabolism | Hepatic via CYP2D6, CYP3A4 |
| Elimination half-life | 3-7 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C15H25NO3 |
| Molar mass | 267.364 g/mol |
| 3D model (JSmol) | |
| Melting point | 120 °C (248 °F) |
| |
| |
| (verify) | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
WARNING See full prescribing information for complete boxed warning.
|